Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2004
10/28/2004US20040214996 Multimeric peptides/immunoglobulins for use in the treatment of bone disorders
10/28/2004US20040214886 for the treatment and/or prophylaxis of diseases, in particular, states of pain and neurodegenerative disorders
10/28/2004US20040214871 Treating cancer with a synergistic mixtures; anticarcinogenic agents; epothilone has secondary amide instead of an ester
10/28/2004US20040214867 Quaternary salts of n-substituted cyclic or acyclic amines as pharmaceuticals
10/28/2004US20040214864 Novel compounds
10/28/2004US20040214843 Such as spiro(cyclohexane-1-4'-(3',4'-dihydro)quinazolin)-2'(1'H)-one for treatment of T-cell-related diseases, autoimmune diseases, osteoarthritis, multiple sclerosis, osteoporosis, asthma and cancer
10/28/2004US20040214839 administering prostaglandin or agonist thereof and type IV selective phosphodiesterase (PDE) inhibitor to induce tolerance to antigens
10/28/2004US20040214821 Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
10/28/2004US20040214814 Pyrazole compounds useful as protein kinase inhibitors
10/28/2004US20040214784 covalent conjugates with mono-, di- , poly- or thiaalkanoic acids; ability to adjust the solubility of steroidal molecules, lipophilicity and bioavailability by altering the structure and length of the acid chain; avoids or reduces the local irritation caused by the parent drug
10/28/2004US20040214759 Compositions and methods of use for a fibroblast growth factor
10/28/2004US20040214165 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
10/28/2004US20040214158 Treatment of human papillomavirus (hpv)-infected cells
10/28/2004US20040213863 extract of Cynanchi Atrati Radix obtained by solvent extraction of crude extract through Diaion resin
10/28/2004US20040213862 comprising Morinda citrifolia fruit juice; treatment of allergies or asthma; increasing glucose production
10/28/2004US20040213849 Modified release dosage forms
10/28/2004US20040213848 Modified release dosage forms
10/28/2004US20040213797 Conjugates for the modulation of immune responses
10/28/2004DE10392164T5 Oral verabreichbare pharmazeutische Formulierung Orally administrable pharmaceutical formulation
10/28/2004CA2718356A1 High concentration antibody and protein formulations
10/28/2004CA2522294A1 Formulations and methods for treating rhinosinusitis
10/28/2004CA2522102A1 Quaternary ammonium compounds and their use as antimuscarinic agents
10/28/2004CA2522076A1 Method for identifying modulators of g protein coupled receptor signaling
10/28/2004CA2522007A1 Methods of preventing or treating respiratory conditions
10/28/2004CA2521841A1 Imidazole derivatives for treatment of allergic and hyperproliferative disorders
10/27/2004EP1471144A1 Biological variability of asthma associated factor, AAF2 (IL-9 receptor), useful in treating and diagnosing atopic allergies including asthma and related disorders
10/27/2004EP1471057A1 Pyrimidinylacetic acid derivatives useful for the treatment of diseases mediated by CRTH2
10/27/2004EP1471055A1 6-phenylpyridyl-2-amine derivatives
10/27/2004EP1471054A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
10/27/2004EP1470826A1 Decoy-containing pharmaceutical compositions and method of using the same
10/27/2004EP1470420A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
10/27/2004EP1470257A2 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA)
10/27/2004EP1470256A2 RNA INTERFERENCE MEDIATED INHIBITION OF GASTRIC INHIBITORY POLYPEPTIDE /GIP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
10/27/2004EP1470218A2 Corona-virus-like particles comprising functionally deleted genomes
10/27/2004EP1470157A2 Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof
10/27/2004EP1470150A2 Corticosteroids nitrate derivatives
10/27/2004EP1470138A1 Mmp inhibitors
10/27/2004EP1470137A1 Edg receptor agonists
10/27/2004EP1470126A1 N-substituted spiropiperidine compounds as ligands for orl-1 receptor
10/27/2004EP1470122A1 Rho-kinase inhibitors
10/27/2004EP1470121A1 Pyrimidine derivatives as rho-kinase inhibitors
10/27/2004EP1470120A1 N-oxyde of n-phenyl-2-pyrimidine-amine derivatives
10/27/2004EP1470112A1 Substituted pyridazinones as inhibitors of p38
10/27/2004EP1470107A2 Fluoro substituted cycloalkanoindoles and their use as prostaglandin d2 receptor antagonists
10/27/2004EP1469880A2 Method for reducing morbidity and mortality in critically ill patients
10/27/2004EP1469878A2 Fgfr agonists
10/27/2004EP1469857A1 Use of pde5 inhibitors in the treatment of scarring and fibrosis
10/27/2004EP1469856A2 8-heteroaryl xanthine adenosine a sb 2b /sb receptor antagonists
10/27/2004EP1469849A1 Treating stress response with chemokine receptor ccr5 modulators
10/27/2004EP1469846A2 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin
10/27/2004EP1469842A2 Bicyclic cb2 cannabinoid receptor ligands
10/27/2004EP1373263B1 Heterocyclic compounds for aging-related and diabetic vascular complications
10/27/2004EP1246791B1 Aminomethyl-phenyl-cyclohexanone derivatives
10/27/2004EP0918461B1 Methods of treating asthma with o-desulfated heparin
10/27/2004EP0813544B1 Bradykinin antagonist peptides incorporating n-substituted glycines
10/27/2004CN1541277A Method of determing chemotherapeutic regimen based on glutachione-S-transferase pi expression
10/27/2004CN1541271A Methods for large scale prodn. of recombinant DNA-derived tPA or K2S molecules
10/27/2004CN1541266A FCE fusion proteins for treatment of allergy and asthma
10/27/2004CN1541224A Antagonistic anti-hTNFSF13b Human antibodies
10/27/2004CN1541217A Chemical compounds
10/27/2004CN1541216A 8-methoxy-(1,2,4) triazolo (1,5-A) pyridine derivatives and their use as adenosine receptor ligands
10/27/2004CN1541214A Novel compounds
10/27/2004CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same
10/27/2004CN1541101A Methods of polyvalent bacteriophage prepn. for treatment of bacterial infections
10/27/2004CN1541095A 抑制炎症的化合物 The compounds inhibit inflammation
10/27/2004CN1539970A Heterophil neutral leucocyte factor alpha
10/27/2004CN1539501A Tablet for keeping in mouth prepared from recombined human interferon alpha 2b and producing method
10/27/2004CN1539500A Nose drops of recombined human interferon alpha 2b and preparing method
10/27/2004CN1539494A Chinese traditional medicine for raising immunocompetence of body for anti influenza, SARS, and preparation method
10/27/2004CN1539493A Combination of Chinese traditional medicine for curing disease of respiratory system and preparing method
10/27/2004CN1539491A Chinese traditional medicine for upper respiratory tract infection
10/27/2004CN1539482A Naristillae for curing rhinopathy
10/27/2004CN1539473A Drug for curing asthma
10/27/2004CN1539452A Granule for strengthening the body resistance and removing epidemic disease
10/27/2004CN1539451A Granule for clearing away the lung-heat and removing poison
10/27/2004CN1539449A Magnetism and drug combined type fragrnant baldric for avoiding plague
10/27/2004CN1539442A Formula of Chinese traditional medicine curing cough and asthma
10/27/2004CN1539414A New medicinal preparation of sodium houttuynine sodium bisulfite and producing method
10/27/2004CN1172952C Mannosan peptide and its prepn and use
10/27/2004CN1172930C PDE IV inhibiting pyridine derivatives
10/27/2004CN1172929C Substituted indoles for modulating NFKB activity
10/27/2004CN1172706C Patent Chinese medicine for treating cough and gasp
10/26/2004US6809199 (Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
10/26/2004US6809175 Cadherin derived growth factor and its use
10/26/2004US6809113 For therapy of arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease, crohn's disease, multiple sclerosis, nephritis, pancreatitis, pulmonary fibrosis, psoriasis, restenosis transplant rejection
10/26/2004US6809108 Selective muscarinic m3 receptor antagonts; reduced side effects
10/26/2004US6809100 Hydroxamic acid derivatives
10/26/2004US6809098 Compounds
10/26/2004US6809092 1,3,4,5-tetrahydro-2h-2-benzazepin-2-yl derivatives; cysteine protease inhibitors
10/26/2004US6809090 Nitrogen monoxide synthase and/or lipidic peroxidation inhibitors
10/26/2004US6809089 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators
10/26/2004US6809077 A cyclic polypeptides; immunosuppressive anti-inflammatory activity, inhibiting antigen-induced inflammatory cell infiltration
10/26/2004CA2266759C 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
10/26/2004CA2137237C Purified forms of dnase
10/26/2004CA2080462C Therapeutic uses of actin-binding compounds
10/21/2004WO2004089913A1 Aminopyrimidine derivatives and their medical use
10/21/2004WO2004089900A1 Azabicyclo derivatives as muscarinic receptor antagonists
10/21/2004WO2004089899A1 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
10/21/2004WO2004089892A2 Diarylmethyl and related compounds having beta2 andrenergic receptor agonist and muscarinic receptor antagonist activity
10/21/2004WO2004089364A1 Azabicyclo derivatives as muscarinic receptor antagonists
1 ... 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 ... 878